Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Corvus Pharmaceuticals (CRVS) Other Working Capital Changes: 2022-2025

Historic Other Working Capital Changes for Corvus Pharmaceuticals (CRVS) over the last 4 years, with Sep 2025 value amounting to -$64,000.

  • Corvus Pharmaceuticals' Other Working Capital Changes rose 81.50% to -$64,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.5 million, marking a year-over-year increase of 146.30%. This contributed to the annual value of $1.6 million for FY2024, which is 229.34% up from last year.
  • According to the latest figures from Q3 2025, Corvus Pharmaceuticals' Other Working Capital Changes is -$64,000, which was down 173.56% from $87,000 recorded in Q2 2025.
  • Corvus Pharmaceuticals' 5-year Other Working Capital Changes high stood at $2.6 million for Q4 2024, and its period low was -$2.1 million during Q4 2023.
  • Over the past 3 years, Corvus Pharmaceuticals' median Other Working Capital Changes value was -$64,000 (recorded in 2025), while the average stood at -$71,364.
  • As far as peak fluctuations go, Corvus Pharmaceuticals' Other Working Capital Changes skyrocketed by 221.94% in 2024, and later slumped by 249.70% in 2025.
  • Corvus Pharmaceuticals' Other Working Capital Changes (Quarterly) stood at -$1.8 million in 2022, then dropped by 17.28% to -$2.1 million in 2023, then soared by 221.94% to $2.6 million in 2024, then soared by 81.50% to -$64,000 in 2025.
  • Its Other Working Capital Changes stands at -$64,000 for Q3 2025, versus $87,000 for Q2 2025 and -$1.2 million for Q1 2025.